The Division of Educational Research has responsibility for the development and coordination of the Center's educational programs. To meet the broad based educational deficit in the area of sickle cell disease, the Division addresses educational needs for patients and families, medical and allied health professionals, and the general community. Past educational activities and assessments have identified priority focal areas for the next funding cycle. The two major areas are a lay education research project and an education core. Division goals are: (1) to assure that adequate community education and outreach services are available for the general public; (2) to enable persons with sickle cell disease and their families to be active and informed participants in the patients' overall health care; (3) to provide sufficient education to enable individuals to make informed and voluntary decisions concerning sickle cell screening; and (5) to enable health care providers to adequately care for and counsel individuals concerning sickle cell disease and trait. Intermediate objectives for accomplishing the above goals are: (1) to provide multilevel education and training programs to meet the educational needs of patients and family members, medical and allied health professionals, vocational and social support agents and the general community; (2) to serve as a regional and national educational resource center; and (3) to make selected community leaders aware of new advances in sickle cell disease screening, management and therapy, as well as related genetic technology needed to increase and improve the effectiveness of community involvement in policy decisions which are not based solely on medical expertise.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL028391-14
Application #
5213398
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
1996
Total Cost
Indirect Cost
Ariens, Robert A S; Lai, Thung-Shenq; Weisel, John W et al. (2002) Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 100:743-54
Ware, Russell E; Eggleston, Barry; Redding-Lallinger, Rupa et al. (2002) Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood 99:10-4
Thompson Jr, Robert J; Gustafson, Kathryn E; Bonner, Melanie J et al. (2002) Neurocognitive development of young children with sickle cell disease through three years of age. J Pediatr Psychol 27:235-44
Slaughter, T F; Sreeram, G; Sharma, A D et al. (2001) Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100 platelet function analyzer. Blood Coagul Fibrinolysis 12:85-93
Lai, T S; Hausladen, A; Slaughter, T F et al. (2001) Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry 40:4904-10
Ataga, K I; Orringer, E P (2000) Renal abnormalities in sickle cell disease. Am J Hematol 63:205-11
Ataga, K I; Orringer, E P (2000) Bone marrow necrosis in sickle cell disease: a description of three cases and a review of the literature. Am J Med Sci 320:342-7
Kinney, T R; Helms, R W; O'Branski, E E et al. (1999) Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood 94:1550-4
Lai, T S; Slaughter, T F; Peoples, K A et al. (1999) Site-directed mutagenesis of the calcium-binding site of blood coagulation factor XIIIa. J Biol Chem 274:24953-8
Slentz-Kesler, K A; Hale, L P; Kaufman, R E (1998) Identification and characterization of K12 (SECTM1), a novel human gene that encodes a Golgi-associated protein with transmembrane and secreted isoforms. Genomics 47:327-40

Showing the most recent 10 out of 78 publications